Runben Biotechnology Co., Ltd. (SHA:603193)
China · Delayed Price · Currency is CNY 22.25
-0.43 (-1.90%)
May 27, 2026, 3:00 PM CST
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 267.09M CNY in the quarter ending March 31, 2026, with 11.27% growth. This brings the company's revenue in the last twelve months to 1.57B, up 12.96% year-over-year. In the year 2025, Runben Biotechnology had annual revenue of 1.54B with 17.19% growth.
Revenue (ttm)
1.57B
Revenue Growth
+12.96%
P/S Ratio
5.73
Revenue / Employee
1.54M
Employees
1,018
Market Cap
9.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 226.61M | 17.19% |
| Dec 31, 2024 | 1.32B | 285.22M | 27.61% |
| Dec 31, 2023 | 1.03B | 176.87M | 20.66% |
| Dec 31, 2022 | 856.09M | 273.94M | 47.06% |
| Dec 31, 2021 | 582.15M | 139.32M | 31.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition